Sputtr.com | Alternative Search Engine

Levothyroxine

Levothyroxine

This information may not cover all possible uses, directions, side effects, precautions, allergic reactions, drug interactions, or withdrawal times.

How to give levothyroxine

Levothyroxine This document is not intended to take the place of the care and attention of your personal physician or other professional medical services.

NEW ZEALAND DATA SHEET

DATA SHEET (Version 4.0) 1 NEW ZEALAND DATA SHEET Levothyroxine Tablets 50microgram, 100microgram Presentations Tablets containing 50 micrograms (0.05mg) or 100 micrograms (0.1mg) anhydrous levothyroxine sodium, which is the monosodium salt of the levorotary isomer of thyroxine.

Levothyroxine - Equine

This information may not cover all possible uses, directions, side effects, precautions, allergic reactions, drug interactions, or withdrawal times.

Eltroxin® Tablets

ELTROXIN TABLETS NZ DATA SHEET - March 2011 Page 1 of 8 NEW ZEALAND DATA SHEET Eltroxin ® Tablets (Levothyroxine Tablets 50 mcg, 100 mcg) PRESENTATION Tablets containing 50 micrograms (0.05 mg) or 100 micrograms (0.1 mg) anhydrous levothyroxine sodium, which is the monosodium salt of the ...

LEVOXYL®

LEVOXYL ® (levothyroxine sodium tablets, USP) DESCRIPTION-LEVOXYL ® (levothyroxine sodium tablets, USP) contain synthetic crystalline L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T 4) sodium].

SYNTHROID®

SYNTHROID ® (levothyroxine sodium tablets, USP) R x only 03-5443-R2-Rev. August, 2005 DESCRIPTION SYNTHROID ® (levothyroxine sodium tablets, USP) contain synthetic crystalline L-3,3',5,5'­ tetraiodothyronine sodium salt [levothyroxine (T4) sodium].

Guidance for Industry

Guidance for Industry Levothyroxine Sodium Products Enforcement of August 14, 2001 Compliance Date and Submission of New Applications U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) July 2001 Procedural

Guidance for Industry

Guidance for Industry Levothyroxine Sodium Tablets — In Vivo Pharmacokinetic and Bioavailability Studies and In Vitro Dissolution Testing U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) December 2000 Clinical Medical

Tirosint™ (levothyroxine sodium)  Capsule [Institut ...

Tirosint™ (levothyroxine sodium) Capsule [Institut Biochimique SA (IBSA)] Rx only DESCRIPTION TIROSINT™ (levothyroxine sodium) capsules are soft gelatin capsules to be orally administered, which contain synthetic L-3,3',5,5'-tetraiodothyronine sodium salt [levothyroxine (T) sodium].